(Q36079849)

12 August 2017

Pathological and biological features of mammographically detected invasive breast carcinomas (English)

1 reference

12 August 2017

Rajakariar R

1

1 reference

12 August 2017

Walker RA

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

1

1 reference

12 August 2017

150-154

1 reference

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Prediction of relapse and survival in breast cancer patients by pS2 protein status

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Comparative pathology of breast cancer in a randomised trial of screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Aggressiveness of breast cancers found with and without screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Pathologic findings in nonpalpable invasive breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Edinburgh trial of screening for breast cancer: mortality at seven years

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Histopathological characteristics and oestrogen receptor content in primary breast carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Cathepsin D and prognosis in breast cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033448

Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project

23 September 2018

1 reference

12 December 2020

A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. British Quality Control Group

1 reference

12 December 2020

Expression of p53 protein in infiltrating and in-situ breast carcinomas

1 reference

12 December 2020

Breast cancer treatment and natural history: new insights from results of screening

1 reference

12 December 2020

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981

1 reference

12 December 2020

Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

1 reference

12 December 2020

pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival

1 reference

12 December 2020

Oestrogen and progesterone receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections

1 reference

12 December 2020

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol

1 reference

12 December 2020

Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.31

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

7819032

1 reference